LifeMD (LFMD) Current Deferred Revenue (2018 - 2025)

LifeMD's Current Deferred Revenue history runs 8 years deep, the most recent figure standing at $10.8 million for Q4 2025.

• Quarterly Current Deferred Revenue fell 36.83% year-over-year to $10.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.8 million (down 36.83% YoY) and the FY2025 annual result came in at $10.8 million, down 36.83% from the prior year.
• Current Deferred Revenue was $10.8 million for Q4 2025 at LifeMD, down from $14.4 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $20.6 million in Q3 2024 and bottomed at $1.3 million in Q1 2021.
• A 5-year average of $8.4 million and a median of $6.1 million in 2023 frame the typical range for Current Deferred Revenue.
• Annual changes were most pronounced in 2021 — Current Deferred Revenue surged 355.08% — and 2025, when it sank 36.83%.
• LifeMD's Current Deferred Revenue stood at $1.5 million in 2021, then soared by 269.86% to $5.5 million in 2022, then soared by 31.08% to $7.3 million in 2023, then jumped by 135.13% to $17.1 million in 2024, then sank by 36.83% to $10.8 million in 2025.
• Business Quant data shows LFMD's Current Deferred Revenue at $10.8 million in Q4 2025, $14.4 million in Q3 2025, and $16.9 million in Q2 2025.